On 11/16/2009, Spring Creek Capital Corp announced that they will be unable to file their next 10-Q by the deadline required by the SEC.

Spring Creek Capital Corporation announced that it has engaged Jennifer McCallum of the McCallum Law Firm in Erie, Colorado to serve as corporate counsel of its newly formed stem cell company AllStem. Ms. McCallum is a patent attorney with a Ph.D. in Biotechnology from Colorado State University and a J.D. from the University of Colorado. She has received numerous awards and accolades in her field, including a 2008 Congressional Medal of Distinction and an appointment by Governor Owens to the Biotechnology Council for the State of Colorado. In addition, Jennifer has received four appointments as the Vice-Chair of the American Bar Association's Committee on Bioethics, and she was one of seven attorneys sponsored in 2006 by the American Bar Association for an in-person en banc lifetime admission to the US Supreme Court. In 2009, she was named one of the Rising Stars in the US legal field by Super Lawyers. Jennifer has extensive international licensing and patenting experience and has a network of 120 affiliate law firms worldwide. She is a highly sought after speaker providing rare insight into complex legal and scientific issues largely centering around pharmaceuticals and stem cell sciences.

Spring Creek Capital Corp. announced that it has completed successful negotiations with veteran stem cell industry pioneer Dwight C Brunoehler to prepare and execute a novel forward looking business plan in the stem cell sector. Mr. Brunoehler has been working in the cord blood stem cell area since 1995 when he established cord blood banks. Cord blood stem cells have been used in more than 11,000 transplants worldwide, to date, mostly for children with life threatening diseases. Mr. Brunoehler was responsible for setting up the first and only nationwide system whereby expectant mothers can sign up to donate their babies' cord blood stem cells from anywhere in the Continental United States, year round. He worked with representatives from Illinois and Wisconsin to draft the first legislation in the country to bring awareness and education to all potential donors in those states. Through his committee work with numerous related organizations, Mr. Brunoehler has been able to establish many unique research and development opportunities including technology licensing in Europe and Asia. A new portfolio company will be formed by the company to undertake the new venture. The mission of the new company will be to provide education and affordable stem cell storage services to all individuals seeking them. In addition, the company will be working with scientists to advance knowledge and uses for stem cells particularly as they relate to personalized medicine. The new company will be working with adult stem cells from various sources in an effort to provide individuals with the ability to take advantage of current and future scientific advancements. Many people who missed the opportunity to store their newborn child's umbilical cord blood are seeking other ways to provide what some have referred to as 'biological insurance'.